Literature DB >> 8431155

Autosomal dominant vitreoretinochoroidopathy. Report of the third family.

E I Traboulsi1, J W Payne.   

Abstract

A family composed of 13 affected members in five generations (10 patients from four generations examined) had vitreal and ophthalmoscopic findings characteristic of autosomal dominant vitreoretinochoroidopathy, as described in two previous kindreds. Visual acuity was 20/25 or better in all but one patient. All affected individuals had vitreous liquefaction with or without peripheral vitreal condensations. Peripheral pigmentary changes and choroidal atrophy were characteristic. Six patients developed cataracts in their early 40s that required extraction. One patient had glaucoma, one developed a retinal detachment, and one had a spontaneous vitreous hemorrhage. Autosomal dominant vitreoretinochoroidopathy is a well-defined condition featuring presenile cataracts, vitreal degeneration, characteristic ophthalmoscopic findings, and good visual prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8431155     DOI: 10.1001/archopht.1993.01090020048021

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  [Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

Authors:  A Alsheikheh; W Lieb; F Grehn
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

2.  BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.

Authors:  A Vincent; C McAlister; C Vandenhoven; E Héon
Journal:  Eye (Lond)       Date:  2010-11-12       Impact factor: 3.775

3.  Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy.

Authors:  Morton F Goldberg; Scott McLeod; Mark Tso; Kirk Packo; Malia Edwards; Imran A Bhutto; Rajkumar Baldeosingh; Charles Eberhart; Bernhard H F Weber; Gerard A Lutty
Journal:  Ophthalmol Retina       Date:  2018-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.